Edition:
United Kingdom

RaQualia Pharma Inc (4579.T)

4579.T on Tokyo Stock Exchange

1,109JPY
24 Nov 2017
Change (% chg)

¥-18 (-1.60%)
Prev Close
¥1,127
Open
¥1,130
Day's High
¥1,140
Day's Low
¥1,108
Volume
421,100
Avg. Vol
1,308,069
52-wk High
¥1,908
52-wk Low
¥371

Summary

Name Age Since Current Position

Naoki Tani

65 President, Chief Executive Officer, Representative Director

Shinichi Koizumi

57 2012 Senior Managing Executive Officer, CSO, Director

Akihiro Furuta

53 2012 Managing Executive Officer, Director

Kiichiro Kawada

Managing Executive Officer

Shuzo Watanabe

Executive Officer

Susumu Tsuchiya

63 2012 Director

Hatsuo Aoki

77 2012 Independent Director

Akimitsu Hirai

53 2010 Independent Director

Sanshiro Horii

Director of Accounting

Biographies

Name Description

Naoki Tani

Mr. Naoki Tani has been serving as President, Chief Executive Officer and Representative Director at RaQualia Pharma Inc. He joined the Company in April 2010 and served as Executive Officer, Managing Executive Officer and Director in the Company. He used to work for a company that is under the new name Astellas Pharma Inc. and Nara Institute of Science and Technology. Mr. Tani obtained his Master's degree in Agricultural Chemistry from Kyoto University in March 1973.

Shinichi Koizumi

Mr. Shinichi Koizumi has been serving as Senior Managing Executive Officer, CSO and Director in RaQualia Pharma Inc. since March 2012. He is also serving as Representative Director in another company. He joined the Company in July 2008 and used to serve as Managing Executive Officer in the Company. He also used to work for Pfizer Japan Inc. and another Japan-based company under the name of Novartis Pharma K.K.

Akihiro Furuta

Mr. Akihiro Furuta has been serving as Managing Executive Officer and Director in RaQualia Pharma Inc. since March 29, 2012. He joined the Company in July 2008. He used to work for a company that is under the new name of Pfizer Japan Inc. and another Japan-based company. He obtained his Bachelor's degree in Literature from Nagoya University.

Kiichiro Kawada

Shuzo Watanabe

Susumu Tsuchiya

Mr. Susumu Tsuchiya has been serving as Director in RaQualia Pharma Inc. He joined the Company in July 2008 and used to serve as Managing Executive Officer in the Company. He used to work for a company that is under the new name Pfizer Japan Inc.

Hatsuo Aoki

Mr. Hatsuo Aoki has been serving as Independent Director in RaQualia Pharma Inc. since March 29, 2012. He is also serving as Independent Director in CxO Advisors, Inc. He used to serve as Chairman of the Board, President, Chief Executive Officer and Representative Director in Fujisawa USA, Inc., as well as Chairman of the Board, President and Representative Director in a company that is under the new name of Astellas Pharma Inc. He obtained his Doctor's degree in Agriculture from The University of Tokyo.

Akimitsu Hirai

Mr. Akimitsu Hirai has been serving as Independent Director in RaQualia Pharma Inc. since March 2010. He is also working for a law firm and another company. He used to serve as Representative Director in alphaGEN Co., Ltd. He obtained his Master's degree in Law from University of Washington in June 1995.

Sanshiro Horii